Sign In
Buy REGN
$628.73
+9.78 (+1.58%)
At Close: Jun 04, 2026
LOS ANGELES, CA / ACCESSWIRE / July 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Regeneron Pharmac
Countdown to Regeneron (REGN) Q2 Earnings: Wall Street Forecasts for Key Metrics
10:21am, Monday, 29'th Jul 2024
Besides Wall Street's top -and-bottom-line estimates for Regeneron (REGN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the
Bull Market Buys: 2 Growth Stocks to Own for the Long Run
07:15am, Saturday, 27'th Jul 2024
Eli Lilly and Regeneron are among the world's leading drugmakers. Both stocks have performed exceptionally well in recent years.
LOS ANGELES, CA / ACCESSWIRE / July 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Regeneron Pharmac
LOS ANGELES, CA / ACCESSWIRE / July 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Regeneron Pharmac
Regeneron (REGN) Earnings Expected to Grow: Should You Buy?
11:07am, Thursday, 25'th Jul 2024
Regeneron (REGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LOS ANGELES, CA / ACCESSWIRE / July 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Regeneron Pharmac
LOS ANGELES, CA / ACCESSWIRE / July 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Regeneron Pharmac
LOS ANGELES, CA / ACCESSWIRE / July 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Regeneron Pharmac
HRMY or REGN: Which Is the Better Value Stock Right Now?
12:46pm, Monday, 22'nd Jul 2024
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Harmony Biosciences Holdings, Inc. (HRMY) and Regeneron (REGN). But which of these two stocks presents investo
LOS ANGELES, CA / ACCESSWIRE / July 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Regeneron Pharmac
LOS ANGELES, CA / ACCESSWIRE / July 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Regeneron Pharmac
3 Standout Stocks to Buy for the Next Bull Market
07:55am, Thursday, 18'th Jul 2024
Wall Street investors are constantly looking for stocks to buy for a bull market. The S&P 500 index has recently reached a new record high, solidifying the bull market that began in October 2022.
Regeneron Pharmaceuticals Inc Investors With Losses Are Invited To Reach Out As The Schall Law Firm Begins An Investigation Into Allegations
03:00pm, Wednesday, 17'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Regeneron Pharmac
Stocks to Buy: 7 Founder-Led Companies Set to Outperform
07:55am, Wednesday, 17'th Jul 2024
What would you say if there was a reliable, evergreen indicator that a company will consistently out-innovate its competitors and, by extension, have a greater chance of long-term survival and market
